Submission Details
| 510(k) Number | K241740 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 17, 2024 |
| Decision Date | July 16, 2024 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K241740 is an FDA 510(k) clearance for the Finesse Injectable? PTA Balloon Dilatation Catheter, a Catheter, Angioplasty, Peripheral, Transluminal (Class II — Special Controls, product code LIT), submitted by Summa Therapeutics (Cambridge, US). The FDA issued a Cleared decision on July 16, 2024, 29 days after receiving the submission on June 17, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K241740 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 17, 2024 |
| Decision Date | July 16, 2024 |
| Days to Decision | 29 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | LIT — Catheter, Angioplasty, Peripheral, Transluminal |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |